Cargando…
Thrombotic Microangiopathy Following Arabian Saw-Scaled Viper (Echis coloratus) Bite: Case Report
Patient: Male, 50-year-old Final Diagnosis: Snake bite induce thromotic microangiopathy Symptoms: Coagulopathy • hemolysis • renal failure • snake bite • thrombocytopenia Medication: — Clinical Procedure: Plasma exchange Specialty: Hematology OBJECTIVE: Unusual clinical course BACKGROUND: Consumptio...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176588/ https://www.ncbi.nlm.nih.gov/pubmed/32291384 http://dx.doi.org/10.12659/AJCR.922000 |
Sumario: | Patient: Male, 50-year-old Final Diagnosis: Snake bite induce thromotic microangiopathy Symptoms: Coagulopathy • hemolysis • renal failure • snake bite • thrombocytopenia Medication: — Clinical Procedure: Plasma exchange Specialty: Hematology OBJECTIVE: Unusual clinical course BACKGROUND: Consumption coagulopathy post envenomation is one the most common complications after a snakebite. It occurs secondary to activation of a coagulation cascade by snake venom and could be followed by a syndrome consistent with thrombotic microangiopathy. The efficacy of plasma exchange for the treatment of thrombotic microangiopathy post envenomation is a matter of debate. CASE REPORT: We reported the case of a 50-year-old male who had Arabian saw-scaled viper envenomation. He developed venom induced coagulopathy that improved within 24 hours of antivenom therapy. He subsequently developed micro-angiopathic hemolytic anemia, thrombocytopenia, and renal failure that was consistent with thrombotic microangiopathy. The patient was treated by plasma exchange and hemodialysis. He made a full recovery and was discharged after 4 weeks. CONCLUSIONS: This case report supports plasmapheresis as an option for management of a patient who develops thrombotic microangiopathy secondary to snake bite, especially those who do not improve with antivenom and supportive therapy. |
---|